A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

NCT04984668 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: GT90001+KN046
DRUG: GT90001+KN046
DRUG: GT90001/KN046
DRUG: GT90001+KN046
DRUG: GT90001+KN046

Sponsor

Suzhou Kintor Pharmaceutical Inc,

Collaborators

[object Object]